BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33360118)

  • 1. Is adjuvant chemotherapy beneficial for stage II-III goblet cell carcinoid/goblet cell adenocarcinoma of the appendix?
    Zakka K; Williamson S; Jiang R; Reid MD; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF; Akce M
    Surg Oncol; 2021 Mar; 36():120-129. PubMed ID: 33360118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of high-risk features for stage II adenocarcinoma of the appendix.
    Akce M; Zakka K; Penley M; Jiang R; Khalil L; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF
    Cancer Treat Res Commun; 2021; 27():100329. PubMed ID: 33609973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Adjuvant Chemotherapy in Non-Metastatic Goblet Cell Carcinoid of the Appendix: An 11-Year Experience from the National Cancer Database.
    AlMasri S; Nassour I; Kowalsky SJ; Hrebinko K; Singhi AD; Lee KK; Choudry HA; Bartlett D; Zureikat A; Paniccia A
    Ann Surg Oncol; 2021 Jul; 28(7):3873-3881. PubMed ID: 33231767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment patterns and outcomes in goblet cell carcinoid tumors of the appendix.
    Fields AC; Lu P; Enzinger A; Goldberg J; Irani J; Bleday R; Nash G; Melnitchouk N
    J Surg Oncol; 2019 Dec; 120(7):1096-1101. PubMed ID: 31592538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Surgical and Chemotherapeutic Treatments of Goblet Cell Carcinoid Tumors of the Appendix.
    Tsang ES; McConnell YJ; Schaeffer DF; Lee L; Yin Y; Zerhouni S; Schaff K; Speers C; Kennecke HF
    Ann Surg Oncol; 2018 Aug; 25(8):2391-2399. PubMed ID: 29916007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base.
    Asare EA; Compton CC; Hanna NN; Kosinski LA; Washington MK; Kakar S; Weiser MR; Overman MJ
    Cancer; 2016 Jan; 122(2):213-21. PubMed ID: 26506400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Two Cases of Goblet Cell Carcinoid of Appendix Treated with Oxaliplatin-Based Adjuvant Chemotherapy].
    Kondo S; Ishizaki T; Wada T; Mazaki J; Iwasaki K; Enomoto M; Nagakawa Y; Katsumata K; Tsuchida A
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2413-2415. PubMed ID: 32156949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Goblet cell carcinoid of the appendix - diagnostic challenges and treatment updates: a case report and review of the literature.
    Gilmore G; Jensen K; Saligram S; Sachdev TP; Arekapudi SR
    J Med Case Rep; 2018 Sep; 12(1):275. PubMed ID: 30244681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Adjuvant Chemotherapy Following Right Hemicolectomy for Non-metastatic Mucinous and Nonmucinous Appendiceal Adenocarcinoma.
    AlMasri SS; Paniccia A; Hammad AY; Pai RK; Bahary N; Zureikat AH; Medich DS; Celebrezze JP; Choudry HA; Nassour I
    J Gastrointest Surg; 2022 Jan; 26(1):171-180. PubMed ID: 34291365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix.
    Tang LH; Shia J; Soslow RA; Dhall D; Wong WD; O'Reilly E; Qin J; Paty P; Weiser MR; Guillem J; Temple L; Sobin LH; Klimstra DS
    Am J Surg Pathol; 2008 Oct; 32(10):1429-43. PubMed ID: 18685490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical and chemotherapy treatment outcomes of goblet cell carcinoid: a tertiary cancer center experience.
    Pham TH; Wolff B; Abraham SC; Drelichman E
    Ann Surg Oncol; 2006 Mar; 13(3):370-6. PubMed ID: 16485156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic profile of appendiceal goblet cell carcinoid is distinct compared to appendiceal neuroendocrine tumor and conventional adenocarcinoma.
    Wen KW; Grenert JP; Joseph NM; Shafizadeh N; Huang A; Hosseini M; Kakar S
    Hum Pathol; 2018 Jul; 77():166-174. PubMed ID: 29634977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appendiceal goblet cell carcinoid: common errors in staging and clinical interpretation with a proposal for an improved terminology.
    Wen KW; Hale G; Shafizadeh N; Hosseini M; Huang A; Kakar S
    Hum Pathol; 2017 Jul; 65():187-193. PubMed ID: 28551326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database analysis.
    Deng A; Wang C; Cohen SJ; Winter JM; Posey J; Yeo C; Basu Mallick A
    Eur J Cancer; 2021 Apr; 147():17-28. PubMed ID: 33607382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell Carcinoids.
    Radomski M; Pai RK; Shuai Y; Ramalingam L; Jones H; Holtzman MP; Ahrendt SA; Pingpank JF; Zeh HJ; Bartlett DL; Choudry HA
    Ann Surg Oncol; 2016 Dec; 23(13):4338-4343. PubMed ID: 27401448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
    Zambrano-Vera K; Sardi A; Munoz-Zuluaga C; Studeman K; Nieroda C; Sittig M; King MC; Sipok A; Gushchin V
    Ann Surg Oncol; 2020 Jan; 27(1):179-187. PubMed ID: 31646450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival with adjuvant chemotherapy in locally advanced rectal cancer patients treated with preoperative chemoradiation regardless of pathologic response.
    Gahagan JV; Whealon MD; Phelan MJ; Mills S; Jafari MD; Carmichael JC; Stamos MJ; Zell JA; Pigazzi A
    Surg Oncol; 2020 Mar; 32():35-40. PubMed ID: 31726418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]   [Full Text] [Related]  

  • 20. Completion of Adjuvant Chemotherapy After Upfront Surgical Resection for Pancreatic Cancer Is Uncommon Yet Associated With Improved Survival.
    Altman AM; Wirth K; Marmor S; Lou E; Chang K; Hui JYC; Tuttle TM; Jensen EH; Denbo JW
    Ann Surg Oncol; 2019 Nov; 26(12):4108-4116. PubMed ID: 31313044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.